Funded Startups in Yerushalayim
Across the 45 most recent funded entries for Yerushalayim, the largest disclosed round is VISIONIX’s $220M on 2026-04-13, which dwarfs the next-largest dis…
Across the 45 most recent funded entries for Yerushalayim, the largest disclosed round is VISIONIX’s $220M on 2026-04-13, which dwarfs the next-largest disclosed amounts (e.g., OrCam Technologies at $181M on 2024-07-28 and Future Meat at $347M on 2021-12-17; within this top-recent slice, the $220M figure stands out sharply above $50M+ peers like Teramount’s $50M on 2025-07-29). At the other extreme, the smallest disclosed amount is Privatise’s $100K on 2021-02-23 (tied with SolidBlock’s $100K on 2021-02-04), highlighting a wide funding range from six-figure rounds to three-figure millions.
Most entries are concentrated around the AI and biotech stack: AI appears in multiple rows (e.g., OrCam Technologies $181M on 2024-07-28; Neteera $13M on 2023-04-12; WISESIGHT undisclosed on 2022-12-18; Il lumigyn $33M on 2021-11-03), while biotech is also frequent (e.g., Splisense $13M on 2026-06-16; Entera Bio $10M on 2026-04-02; Nectin Therapeutics $10M on 2024-05-06). Temporally, the newest round date shown is 2026-06-16 (Splisense), while the oldest shown is 2020-02-26 (Strattic).
Most recent rounds
45 shownRelated listings
Frequently asked
What stands out most in round size for Yerushalayim—does one deal dominate the rest?
VISIONIX’s $220M on 2026-04-13 is the largest disclosed amount in the 45-row view, and it is far above the surrounding disclosed “upper tier” deals such as OrCam Technologies at $181M (2024-07-28) and Teramount at $50M (2025-07-29). The lower tail reaches $100K (Privatise on 2021-02-23 and SolidBlock on 2021-02-04), showing the spread spans from pre-seed scale to three-figure million rounds.
Are certain cities within the Yerushalayim axis over-represented (e.g., Jerusalem vs nearby localities)?
Jerusalem is the dominant locality across the list, appearing on entries like Splisense ($13M, 2026-06-16) and Teramount ($50M, 2025-07-29). Nearby localities show up repeatedly but more sporadically—for example Neve Ilan/Beit-shemesh/Beit Neqofa appear with single or few rows such as Nanox Imaging ($15M, Neve Ilan, 2025-11-23) and Air Doctor ($20M, Beit Neqofa, 2024-10-01).
How much of the dataset has undisclosed funding amounts or missing stage detail?
Undisclosed amounts appear multiple times, including AccuBeat (undisclosed, 2025-10-10), Joyned (undisclosed, 2023-12-14), Olive Diagnostics (undisclosed, 2023-03-09), and WISESIGHT (undisclosed, 2022-12-18). Separately, “Series Unknown” is common across the table (e.g., Splisense 2026-06-16; Adenocyte 2026-05-26; VISIONIX 2026-04-13), while some rows show a blank stage label (e.g., KAHR medical $47M on 2021-06-16).
Which sector cluster appears most consistently in the recent mix: AI or biotech?
AI shows up across several disclosed and undisclosed rounds, including OrCam Technologies ($181M, 2024-07-28), Neteera ($13M, 2023-04-12), WISESIGHT (undisclosed, 2022-12-18), and Illumigyn ($33M, 2021-11-03). Biotech is also repeatedly represented with companies such as Splisense ($13M, 2026-06-16), Entera Bio ($10M, 2026-04-02), Nectin Therapeutics ($10M, 2024-05-06), and Future Meat ($347M, 2021-12-17).
Are there any notable temporal edges or bursts, based on the oldest and newest rounds shown?
The newest disclosed round date in the 45-row view is 2026-06-16 (Splisense, $13M), while the oldest shown is 2020-02-26 (Strattic, $7M). The spread spans about six years, with multiple entries appearing in 2021-05 to 2021-06 (e.g., Revelator $1M on 2021-05-28; Diptera.ai $3M on 2021-06-11; VOTIS subdermal imaging $3M on 2021-06-01), suggesting a mid-2021 concentration among the listed years.
Which outliers are worth checking because they sit far from typical deal sizes or stage labels?
Two extremes are visible: large outlier funding includes Future Meat’s $347M (2021-12-17) and VISIONIX’s $220M (2026-04-13), while the smallest disclosed amounts are $100K rounds (Privatise on 2021-02-23; SolidBlock on 2021-02-04). There are also stage-label outliers such as Debt Financing (iwi Life, $6M on 2022-01-18) alongside standard equity-style labels like Series A and Series B.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.